Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting.

MLA

Jones, Bruce M., et al. “Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting.” Open Forum Infectious Diseases, vol. 7, no. 2, Jan. 2020, p. ofaa014. EBSCOhost, https://doi.org/10.1093/ofid/ofaa014.

APA

Jones, B. M., Huelfer, K., & Bland, C. M. (2020). Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting. Open Forum Infectious Diseases, 7(2), ofaa014. https://doi.org/10.1093/ofid/ofaa014

Chicago

Jones, Bruce M, Kathryn Huelfer, and Christopher M Bland. 2020. “Clinical and Safety Evaluation of Continuously Infused Ceftolozane/Tazobactam in the Outpatient Setting.” Open Forum Infectious Diseases 7 (2): ofaa014. doi:10.1093/ofid/ofaa014.